271 related articles for article (PubMed ID: 9926942)
21. Increased expression of integrin beta1 subunit enhances p21WAF1/Cip1 transcription through the Sp1 sites and p300-mediated histone acetylation in human hepatocellular carcinoma cells.
Fang Z; Fu Y; Liang Y; Li Z; Zhang W; Jin J; Yang Y; Zha X
J Cell Biochem; 2007 Jun; 101(3):654-64. PubMed ID: 17211849
[TBL] [Abstract][Full Text] [Related]
22. HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage.
Di Stefano V; Soddu S; Sacchi A; D'Orazi G
Oncogene; 2005 Aug; 24(35):5431-42. PubMed ID: 15897882
[TBL] [Abstract][Full Text] [Related]
23. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements.
Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G
Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705
[TBL] [Abstract][Full Text] [Related]
24. BRCA1 splice variants BRCA1a and BRCA1b associate with CBP co-activator.
Cui JQ; Shao N; Chai Y; Wang H; Reddy ES; Rao VN
Oncol Rep; 1998; 5(3):591-5. PubMed ID: 9538157
[TBL] [Abstract][Full Text] [Related]
25. Tamoxifen-induced activation of p21Waf1/Cip1 gene transcription is mediated by Early Growth Response-1 protein through the JNK and p38 MAP kinase/Elk-1 cascades in MDA-MB-361 breast carcinoma cells.
Kim CG; Choi BH; Son SW; Yi SJ; Shin SY; Lee YH
Cell Signal; 2007 Jun; 19(6):1290-300. PubMed ID: 17307334
[TBL] [Abstract][Full Text] [Related]
26. Alternative pathway of transcriptional induction of p21WAF1/Cip1 by cyclosporine A in p53-deficient human glioblastoma cells.
Zupanska A; Adach A; Dziembowska M; Kaminska B
Cell Signal; 2007 Jun; 19(6):1268-78. PubMed ID: 17321721
[TBL] [Abstract][Full Text] [Related]
27. BRCA1a has antitumor activity in TN breast, ovarian and prostate cancers.
Yuli C; Shao N; Rao R; Aysola P; Reddy V; Oprea-llies G; Lee L; Okoli J; Partridge E; Reddy ES; Rao VN
Oncogene; 2007 Sep; 26(41):6031-7. PubMed ID: 17384678
[TBL] [Abstract][Full Text] [Related]
28. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.
Inga A; Resnick MA
Oncogene; 2001 Jun; 20(26):3409-19. PubMed ID: 11423991
[TBL] [Abstract][Full Text] [Related]
29. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells.
Kawai H; Li H; Chun P; Avraham S; Avraham HK
Oncogene; 2002 Oct; 21(50):7730-9. PubMed ID: 12400015
[TBL] [Abstract][Full Text] [Related]
30. Physical and functional interactions between members of the tumour suppressor p53 and the Sp families of transcription factors: importance for the regulation of genes involved in cell-cycle arrest and apoptosis.
Koutsodontis G; Vasilaki E; Chou WC; Papakosta P; Kardassis D
Biochem J; 2005 Jul; 389(Pt 2):443-55. PubMed ID: 15790310
[TBL] [Abstract][Full Text] [Related]
31. Comparison of BRCT domains of BRCA1 and 53BP1: a biophysical analysis.
Ekblad CM; Friedler A; Veprintsev D; Weinberg RL; Itzhaki LS
Protein Sci; 2004 Mar; 13(3):617-25. PubMed ID: 14978302
[TBL] [Abstract][Full Text] [Related]
32. In vitro transcriptional activation of p21 promoter by p53.
Kim TK
Biochem Biophys Res Commun; 1997 May; 234(2):300-2. PubMed ID: 9177263
[TBL] [Abstract][Full Text] [Related]
33. BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A.
Anderson SF; Schlegel BP; Nakajima T; Wolpin ES; Parvin JD
Nat Genet; 1998 Jul; 19(3):254-6. PubMed ID: 9662397
[TBL] [Abstract][Full Text] [Related]
34. Mitochondrial localization, ELK-1 transcriptional regulation and growth inhibitory functions of BRCA1, BRCA1a, and BRCA1b proteins.
Maniccia AW; Lewis C; Begum N; Xu J; Cui J; Chipitsyna G; Aysola K; Reddy V; Bhat G; Fujimura Y; Henderson B; Reddy ES; Rao VN
J Cell Physiol; 2009 Jun; 219(3):634-41. PubMed ID: 19170108
[TBL] [Abstract][Full Text] [Related]
35. BRCA1 regulates p53-dependent gene expression.
Ouchi T; Monteiro AN; August A; Aaronson SA; Hanafusa H
Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2302-6. PubMed ID: 9482880
[TBL] [Abstract][Full Text] [Related]
36. Structure of an XRCC1 BRCT domain: a new protein-protein interaction module.
Zhang X; Moréra S; Bates PA; Whitehead PC; Coffer AI; Hainbucher K; Nash RA; Sternberg MJ; Lindahl T; Freemont PS
EMBO J; 1998 Nov; 17(21):6404-11. PubMed ID: 9799248
[TBL] [Abstract][Full Text] [Related]
37. Regulated recruitment of tumor suppressor BRCA1 to the p21 gene by coactivator methylation.
Lee YH; Bedford MT; Stallcup MR
Genes Dev; 2011 Jan; 25(2):176-88. PubMed ID: 21245169
[TBL] [Abstract][Full Text] [Related]
38. Tumour associated mutants of p53 can inhibit transcriptional activity of p53 without heterooligomerization.
Jõers A; Kristjuhan A; Kadaja L; Maimets T
Oncogene; 1998 Nov; 17(18):2351-8. PubMed ID: 9811466
[TBL] [Abstract][Full Text] [Related]
39. Sp1 plays a critical role in the transcriptional activation of the human cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by the p53 tumor suppressor protein.
Koutsodontis G; Tentes I; Papakosta P; Moustakas A; Kardassis D
J Biol Chem; 2001 Aug; 276(31):29116-25. PubMed ID: 11384995
[TBL] [Abstract][Full Text] [Related]
40. CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein.
Scolnick DM; Chehab NH; Stavridi ES; Lien MC; Caruso L; Moran E; Berger SL; Halazonetis TD
Cancer Res; 1997 Sep; 57(17):3693-6. PubMed ID: 9288775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
